Nasdaq
$38.71▼ 0.13%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.11BShares out 28.7M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
21- 10.13After-hours26.10.14 05:104Ownership#●●●
LB PHARMACEUTICALS INC
Insider Miller Joseph M filed a Form 4 regarding changes in beneficial ownership of securities for LB PHARMACEUTICALS INC on October 9, 2026. This filing serves as an official record of the insider's equity transaction.…more
$38.71-0.13%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.13After-hours26.10.14 05:104Ownership
LB PHARMACEUTICALS INC
Insider Susan Gani of LB PHARMACEUTICALS INC filed a Form 4 on October 13, 2026, reporting a change in beneficial ownership of securities as of October 9, 2026. This filing serves as a standard disclosure regarding the insider's equity holdings.…more
$38.71-0.13%vs prev closeView filingShare - 10.13Regular26.10.14 02:46SCHEDULE 13G/AOwnership
LB PHARMACEUTICALS INC
JPMorgan Chase & Co. has filed a SCHEDULE 13G/A regarding its beneficial ownership in LB PHARMACEUTICALS INC. This filing serves as an amendment to the previously reported ownership status.…more
$38.71-0.13%vs prev closeView filingShare
20 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.15After-hours26.10.16 05:05#●●●#●●●
LB Pharmaceuticals to Participate in Upcoming Investor Events
LB Pharmaceuticals announced that its executive team will participate in several upcoming healthcare investor conferences throughout October and November. These scheduled appearances are standard corporate activities and do not provide immediate material impact on the stock.…more
$38.71-0.13%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.10Closed26.10.10 21:00
●●●●●●●● ●●●●● ●●●●●●
LB Pharmaceuticals shared new preclinical data and clinical progress for its lead candidate LB-102 at the ECNP Congress. While the data strengthens the scientific rationale for its neuropsychiatric programs, it remains part of ongoing development without immediate commercial impact.…more
$38.71-0.13%vs prev close - 10.9After-hours26.10.10 05:42
●●●●●●●● ●●●●● ●●●●●●
LB Pharmaceuticals has granted stock options for 200,000 shares each to its new Chief Medical Officer and Chief Financial Officer. These inducement grants were issued as part of the compensation package for the new executive appointments.…more
$38.71-0.13%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report